Symbol="SLRX"
AssetType="Common Stock"
Name="Salarius Pharmaceuticals Inc"
Description="Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, is focused on developing epigenetics-based cancer treatments. The company is headquartered in Houston, Texas."
CIK="1615219"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="4827000"
EBITDA="-22275116"
PERatio="None"
PEGRatio="0"
BookValue="2.252"
DividendPerShare="0"
DividendYield="0"
EPS="-15.8"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.611"
ReturnOnEquityTTM="-1.583"
RevenueTTM="0"
GrossProfitTTM="-15836828"
DilutedEPSTTM="-15.8"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="46.58"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="18.12"
PriceToBookRatio="0.252"
EVToRevenue="0.137"
EVToEBITDA="1.562"
Beta="1.153"
num_52WeekHigh="7.2"
num_52WeekLow="1.07"
num_50DayMovingAverage="1.559"
num_200DayMovingAverage="2.22"
SharesOutstanding="3352100"
DividendDate="2019-07-22"
ExDividendDate="None"
symbol="SLRX"
open="1.52"
high="1.55"
low="1.41"
price="1.44"
volume="20933.00"
latest_trading_day="2023-07-07"
previous_close="1.51"
change="-0.07"
change_percent="-4.6358%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="57"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="43"
Volume_recent_avg="75349"
Change_recent_avg="-0.02"
Delta_recent_avg="0.15"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.95"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="43"
Aroon_momentum_negative="57"
image_negative_thumbnail_id_1="165"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0011.jpeg"
image_negative_thumbnail_id_2="1140"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0173.jpeg"
image_neutral_thumbnail_id_1="555"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0044.jpeg"
image_neutral_thumbnail_id_2="570"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0029.jpeg"
image_positive_thumbnail_id_1="607"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0101.jpeg"
image_positive_thumbnail_id_2="990"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0152.jpeg"
image_professor_thumbnail_id_1="1193"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
image_professor_thumbnail_id_2="1191"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
